Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

Increased levels of an endogenous inhibitor of tissue-plasminogen activator (t-PA) have been thought to relate to the genesis of acute myocardial ischemia. To examine the role of the rapid inhibitor of t-PA, plasma samples were analyzed from 75 patients with chest pain syndrome undergoing coronary angiography (mean age 57 years), 24 patients with clinically documented coronary artery disease (unstable angina, positive exercise stress test or previous history of myocardial infarction; mean age 58 years) and 15 young normal subjects (mean age 26 years). Plasma t-PA inhibitor levels were similar in age-matched patients regardless of the absence or presence (and degree) of coronary artery disease. Plasma t-PA inhibitor levels correlated significantly with age (r - 0.46, p less than 0.005), suggesting an age-dependent decrease in fibrinolytic activity. Plasma t-PA inhibitor levels also correlated significantly with serum triglyceride levels (r - 0.60, p less than 0.001), but not with coronary risk factors such as serum cholesterol, diabetes, hypertension, serum uric acid levels or body weight. Association of high levels of inhibitor of t-PA with hypertriglyceridemia may be of importance in the development of coronary thrombosis, especially in elderly patients. Nonetheless, this study does not suggest a pathogenic role of t-PA inhibitor in coronary atherosclerosis.

This article has been cited by other articles:

				R. Serrano, J. Barrenetxe, J. Orbe, J. A. Rodriguez, N. Gallardo, C. Martinez, A. Andres, and J. A. Paramo Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1563 - R1569. [Abstract] [Full Text] [PDF]

				S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF]

				K. A. Meckling, C. O'Sullivan, and D. Saari Comparison of a Low-Fat Diet to a Low-Carbohydrate Diet on Weight Loss, Body Composition, and Risk Factors for Diabetes and Cardiovascular Disease in Free-Living, Overweight Men and Women J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2717 - 2723. [Abstract] [Full Text] [PDF]

				K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]

				K. Yamamoto, K. Takeshita, T. Shimokawa, H. Yi, K.-i. Isobe, D. J. Loskutoff, and H. Saito Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals PNAS, January 22, 2002; 99(2): 890 - 895. [Abstract] [Full Text] [PDF]

				J. Calles-Escandon and M. Cipolla Diabetes and Endothelial Dysfunction: A Clinical Perspective Endocr. Rev., February 1, 2001; 22(1): 36 - 52. [Abstract] [Full Text] [PDF]

				Y. Chen, J. J. Billadello, and D. J. Schneider Identification and Localization of a Fatty Acid Response Region in the Human Plasminogen Activator Inhibitor-1 Gene Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2696 - 2701. [Abstract] [Full Text] [PDF]

				K. A. Poli, G. H. Tofler, M. G. Larson, J. C. Evans, P. A. Sutherland, I. Lipinska, M. A. Mittleman, J. E. Muller, R. B. D Agostino, P. W. F. Wilson, et al. Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population Circulation, January 25, 2000; 101(3): 264 - 269. [Abstract] [Full Text] [PDF]

				C. Banfi, L. Mussoni, P. Rise, M. G. Cattaneo, L. Vicentini, F. Battaini, C. Galli, and E. Tremoli Very Low Density Lipoprotein Mediated Signal Transduction and Plasminogen Activator Inhibitor Type 1 in Cultured HepG2 Cells Circ. Res., July 23, 1999; 85(2): 208 - 217. [Abstract] [Full Text] [PDF]

				L. Nilsson, C. Banfi, U. Diczfalusy, E. Tremoli, A. Hamsten, and P. Eriksson Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1679 - 1685. [Abstract] [Full Text] [PDF]

				H. E. Grenett, R. L. Benza, G. M. Fless, X.-N. Li, G. C. Davis, and F. M. Booyse Genotype-Specific Transcriptional Regulation of PAI-1 Gene by Insulin, Hypertriglyceridemic VLDL, and Lp(a) in Transfected, Cultured Human Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1803 - 1809. [Abstract] [Full Text] [PDF]

				A. Geppert, S. Graf, R. Beckmann, S. Hornykewycz, E. Schuster, B. R. Binder, and K. Huber Concentration of Endogenous tPA Antigen in Coronary Artery Disease : Relation to Thrombotic Events, Aspirin Treatment, Hyperlipidemia, and Multivessel Disease Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1634 - 1642. [Abstract] [Full Text] [PDF]

				J o. Jeppesen, H. O. Hein, P. Suadicani, and F. Gyntelberg Triglyceride Concentration and Ischemic Heart Disease : An Eight-Year Follow-up in the Copenhagen Male Study Circulation, March 24, 1998; 97(11): 1029 - 1036. [Abstract] [Full Text] [PDF]

				T. A. B. Sanders, F. R. Oakley, G. J. Miller, K. A. Mitropoulos, D. Crook, and M. F. Oliver Influence of n-6 versus n-3 Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3449 - 3460. [Abstract] [Full Text]

				X.-N. Li, H. E. Grenett, R. L. Benza, S. Demissie, S. L. Brown, E. M. Tabengwa, S. H. Gianturco, W. A. Bradley, G. M. Fless, and F. M. Booyse Genotype-Specific Transcriptional Regulation of PAI-1 Expression by Hypertriglyceridemic VLDL and Lp(a) in Cultured Human Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3215 - 3223. [Abstract] [Full Text]

				D. J. Schneider, M. A. Ricci, D. J. Taatjes, P. Q. Baumann, J. C. Reese, B. J. Leavitt, P. M. Absher, and B. E. Sobel Changes in Arterial Expression of Fibrinolytic System Proteins in Atherogenesis Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3294 - 3301. [Abstract] [Full Text]

				J. Jeppesen, H. O. Hein, P. Suadicani, and F. Gyntelberg Relation of High TG Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease: An 8-Year Follow-up in the Copenhagen Male Study Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1114 - 1120. [Abstract] [Full Text]

				A. Panahloo and J. S. Yudkin Diminished Fibrinolysis in Diabetes Mellitus and its Implication for Diabetic Vascular Disease European Journal of Cardiovascular Prevention & Rehabilitation, April 1, 1997; 4(2): 91 - 99. [PDF]

				A. Broijersen, M. Eriksson, B. Wiman, B. Angelin, and P. Hjemdahl Gemfibrozil Treatment of Combined Hyperlipoproteinemia : No Improvement of Fibrinolysis Despite Marked Reduction of Plasma Triglyceride Levels Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 511 - 516. [Abstract] [Full Text]

				D. Zitoun, L. Bara, A. Basdevant, and M. M. Samama Levels of Factor VIIc Associated With Decreased Tissue Factor Pathway Inhibitor and Increased Plasminogen Activator Inhibitor-1 in Dyslipidemias Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 77 - 81. [Abstract] [Full Text]

				L. Sironi, L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, and E. Tremoli Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 89 - 96. [Abstract] [Full Text]

				S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Predictors of Stroke in Middle-Aged Patients With Non Insulin-Dependent Diabetes Stroke, January 1, 1996; 27(1): 63 - 68. [Abstract] [Full Text]

				M. P. Stern Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents? Ann Intern Med, January 1, 1996; 124(1_Part_2): 110 - 116. [Abstract] [Full Text]

				O. C. E. Gebara, M. A. Mittleman, P. Sutherland, I. Lipinska, T. Matheney, P. Xu, F. K. Welty, P. W. F. Wilson, D. Levy, J. E. Muller, et al. Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study Circulation, April 1, 1995; 91(7): 1952 - 1958. [Abstract] [Full Text]

				D. F. Altomare, N. Semeraro, and M. Colucci Reduction of the Plasma Levels of Tissue Plasminogen Activator After Infusion of a Lipid Emulsion in Humans JPEN J Parenter Enteral Nutr, May 1, 1993; 17(3): 274 - 276. [Abstract] [PDF]

				D. G. Meyers, W. D. Haire, J. K. Rasmussen, and E. J. Boyd Tissue Plasminogen Activator Release and Plasminogen Activator Inhibitor Levels in Coronary Artery Disease Angiology, July 1, 1991; 42(7): 561 - 567. [Abstract] [PDF]

				A. Hamsten Myocardial infarction at a young age: mechanisms and management Vascular Medicine, March 1, 1991; 2(1): 45 - 60. [PDF]

				R. C. BECKER and J. M. CORRAO Marine Omega-3 Fatty Acids and Atherosclerosis Ann Intern Med, April 1, 1988; 108(4): 641 - 641. [Abstract] [PDF]

				K. Yamamoto, K. Takeshita, T. Shimokawa, H. Yi, K.-i. Isobe, D. J. Loskutoff, and H. Saito Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals PNAS, January 22, 2002; 99(2): 890 - 895. [Abstract] [Full Text] [PDF]